ShareThis Page
Buy and sell recommendations on the 20 largest stocks |

Buy and sell recommendations on the 20 largest stocks

My bread and butter are small-cap and mid-cap stocks. But many people stick to the largest stocks, so once a year I offer my buy and sell recommendations on the 20 biggest in the United States.

One-year total returns
for the previous 14 columns have averaged 12.4 percent
on my buy-rated stocks,
11.1 percent on the “avoids” and 10.7 percent on the neutral ratings, which I try to keep to a minimum.

For comparison, the Standard & Poor’s 500 Index has averaged a 13.7 percent return over the same 14 periods. Thus, the very largest stocks have underperformed the overall market.

Bear in mind, my column recommendations are theoretical and don’t reflect actual trades, trading costs or taxes. Their results shouldn’t be confused with the performance of portfolios I manage for clients. And past performance doesn’t predict future results.

Atop the chain

Apple Inc. (AAPL,
$1.08 trillion) is fighting against precedent. Normally, the stock at the top of the food chain is a mediocre performer. However, I believe that Apple is still innovating and will continue to grow. Buy. (AMZN,
$961 billion) broke the trillion-dollar barrier briefly last week. Analysts foresee giant profit jumps in the next two years. But the stock sells for 76 times their 2019 estimates and 200 times recent results. Avoid.

Microsoft Corp. (MSFT, $869 billion) seems to be back on the growth track, after a stall-out a couple of years ago. But would I pay 32 times earnings and 10 times book value (corporate net worth) for it? No. Avoid.

Alphabet Inc. (GOOGL, $817 billion) is the parent of Google and YouTube. I’ll pay up for this one. At 30 times earnings, it’s cheaper than Amazon and has a much better balance sheet. Buy.

Berkshire Hathaway (BRK.A and BRK.B, $534 billion) is the conglomerate run by the legendary investor Warren Buffett. It has a rich history of first-class returns. Buy.

Policing costs

Facebook Inc. (FB,
$469 billion) is popular. But I feel that analysts’ profit estimates are too high, because I believe the company will have to spend heavily to police fake content and hate speech on its site. Avoid.

J.P. Morgan Chase & Co. (JPM, $381 billion) should benefit from rising interest rates over the next two to three years, helping to widen the spread between loan rates and the cost of funds. Buy.

Johnson & Johnson (JNJ, $374 million) has multiple profit centers, and I believe it’s well run. Profitability has weakened lately, so I’m a worried bull. Buy.

Exxon Mobil Corp. (XOM, $351 billion). In the oil industry, Exxon often gets the first crack at the finest engineers, drillers and fields. The dividend yield looks nice at about 3.9 percent. Buy.

Bank of America Corp. (BAC, $303 billion) has about 4,600 branches and 16,000 automated teller machines (ATMs). I like it for the same reason I like J.P. Morgan, but not quite as much. Buy.

No thanks

Visa Inc. (V, $301 billion) is a fine company. Nevertheless, with the stock having tripled in four years, I’d stand aside. Avoid.

Walmart Inc . (WMT,
$277 billion). Profitability at the nation’s largest retailer has declined five years in a row. Avoid.

Wells Fargo & Co. (WFC, $264 billion) lost public trust through a series of scandals, some of which involved opening fictitious accounts. I prefer other banks. Avoid.

UnitedHealth Group Inc. (UNH, $255 billion), a managed care company, has grown its revenue and earnings at a double-digit pace over the past
10 years. Profits are strong, with almost a 26 percent return on stockholders’ equity last year. Buy.

Pfizer Inc. (PFE, $252 billion) is no longer an investor favorite but still shows consistent earnings growth and high profitability. Buy.

Fat yield

AT&T Inc. (T, $244 billion) has a fat 6 percent dividend yield as its biggest attraction. In June, it acquired Time Warner Inc., adding a lot of content to spread through its huge distribution network. The stock is reasonably priced at 12 times earnings. Buy.

Home Depot Inc. (HD,
$239 billion) carries a frightening debt loan, about 18 times stockholders’ equity. The stock sells for 119 times book value (corporate net worth). Avoid.

Mastercard Inc. (MA,
$226 billion) is too rich for my blood personally, but the stock has risen almost 1,000 percent in the past eight years and one of my colleagues loves it. Neutral.

Verizon Communications Inc. (VZ, $225 billion) made a good move, in my opinion, by acquiring AOL and Yahoo. Revenue hasn’t been growing much lately, and debt is on the high side. Avoid.

Chevron Corp. (CVX,
$224 billion) seems to be recovering nicely from the oil-price swoon of June 2014 to February 2016. I think it will be a buy sometime soon, but not yet. Neutral.

Disclosure: For most of my clients and personally, I own Alphabet, Apple, Berkshire Hathaway, Mastercard and UnitedHealth Group. Some clients own Chevron, J.P. Morgan Chase and Visa. Some of my family members own

John Dorfman is chairman of Dorfman Value Investments LLC in Newton Upper Falls, Mass., and a syndicated columnist. His firm or clients may own or trade securities discussed in this column. He can be reached at [email protected] .

TribLIVE commenting policy

You are solely responsible for your comments and by using you agree to our Terms of Service.

We moderate comments. Our goal is to provide substantive commentary for a general readership. By screening submissions, we provide a space where readers can share intelligent and informed commentary that enhances the quality of our news and information.

While most comments will be posted if they are on-topic and not abusive, moderating decisions are subjective. We will make them as carefully and consistently as we can. Because of the volume of reader comments, we cannot review individual moderation decisions with readers.

We value thoughtful comments representing a range of views that make their point quickly and politely. We make an effort to protect discussions from repeated comments either by the same reader or different readers

We follow the same standards for taste as the daily newspaper. A few things we won't tolerate: personal attacks, obscenity, vulgarity, profanity (including expletives and letters followed by dashes), commercial promotion, impersonations, incoherence, proselytizing and SHOUTING. Don't include URLs to Web sites.

We do not edit comments. They are either approved or deleted. We reserve the right to edit a comment that is quoted or excerpted in an article. In this case, we may fix spelling and punctuation.

We welcome strong opinions and criticism of our work, but we don't want comments to become bogged down with discussions of our policies and we will moderate accordingly.

We appreciate it when readers and people quoted in articles or blog posts point out errors of fact or emphasis and will investigate all assertions. But these suggestions should be sent via e-mail. To avoid distracting other readers, we won't publish comments that suggest a correction. Instead, corrections will be made in a blog post or in an article.